Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study93

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study41

Views

Views
May 20255
June 20255
July 202513
August 20254
September 20256
October 20253
November 20255
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil16
United States14
Hong Kong3
Argentina1
Austria1
Ecuador1
Egypt1
United Kingdom1
Morocco1
Paraguay1
 

Top cities views

Views
Hong Kong3
Americana1
Bauru1
Belo Horizonte1
Cairo1
Campo Novo do Parecis1
Canton1
Casablanca1
Caxias do Sul1
Cincinnati1